Difference between revisions of "IolG"
(→Extended information on the protein) |
|||
Line 83: | Line 83: | ||
* '''Effectors of protein activity:''' | * '''Effectors of protein activity:''' | ||
− | * '''Interactions:''' the protein forms a tetramer {{PubMed|20809899}} | + | * '''[[SubtInteract|Interactions]]:''' |
+ | ** the protein forms a tetramer {{PubMed|20809899}} | ||
− | * '''Localization:''' | + | * '''[[Localization]]:''' |
=== Database entries === | === Database entries === |
Revision as of 16:16, 10 August 2011
- Description: inositol 2-dehydrogenase
Gene name | iolG |
Synonyms | idh, iol |
Essential | no |
Product | inositol 2-dehydrogenase |
Function | myo-inositol catabolism |
Metabolic function and regulation of this protein in SubtiPathways: Sugar catabolism | |
MW, pI | 38 kDa, 4.865 |
Gene length, protein length | 1032 bp, 344 aa |
Immediate neighbours | iolH, iolF |
Get the DNA and protein sequences (Barbe et al., 2009) | |
Genetic context This image was kindly provided by SubtiList
|
Contents
Categories containing this gene/protein
utilization of specific carbon sources
This gene is a member of the following regulons
The gene
Basic information
- Locus tag: BSU39700
Phenotypes of a mutant
Database entries
- DBTBS entry: [1]
- SubtiList entry: [2]
Additional information
The protein
Basic information/ Evolution
- Catalyzed reaction/ biological activity: Myo-inositol + NAD+ = 2,4,6/3,5-pentahydroxycyclohexanone + NADH (according to Swiss-Prot)
- Protein family: gfo/idh/mocA family (according to Swiss-Prot)
Extended information on the protein
- Kinetic information:
- Domains:
- Modification:
- Cofactor(s): NAD(+) PubMed
- Effectors of protein activity:
- Interactions:
- the protein forms a tetramer PubMed
Database entries
- UniProt: P26935
- KEGG entry: [3]
- E.C. number: 1.1.1.18
Additional information
Expression and regulation
- Additional information:
Biological materials
- Mutant:
- Expression vector:
- lacZ fusion:
- GFP fusion:
- two-hybrid system:
- Antibody:
Labs working on this gene/protein
- Yasutaro Fujita, University of Fukuyama, Japan
- Ken-ichi Yoshida, Kobe University, Japan
Your additional remarks
References
Additional publications: PubMed